omniture
康诺亚生物医药科技有限公司

Latest News

CMG901 for the treatment of gastric cancer and gastroesophageal junction adenocarcinoma was granted the Orphan-drug Designation by the Food and Drug Administration of the United States

CHENGDU, China, April 12, 2022 /PRNewswire/ -- Keymed Biosciences (2162.HK) announced that its new ...

2022-04-12 15:45 1255

Keymed Biosciences Releases 2021 Annual Results

CHENGDU, China, March 30, 2022 /PRNewswire/ -- Keymed Biosciences Inc. (HKEX Code: 02162) released ...

2022-03-30 23:41 2867

Keymed has been included as eligible stocks of the Shenzhen-Hong Kong Stock Connect

CHENGDU, China, March 7, 2022 /PRNewswire/ -- Keymed Biosciences Inc. (2162.HK) is pleased to annou...

2022-03-07 15:57 2949

Keymed Bio Joins Hang Seng Family of Indexes

HONG KONG, Feb. 18, 2022 /PRNewswire/ --  According to the quarterly review results of Hang Seng Fa...

2022-02-18 22:10 7020
12